<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pan J</submitter><funding>Fundamental Research Funds for the Central Universities</funding><funding>Natural Science Foundation of Shandong Province</funding><funding>National Science Foundation of China</funding><funding>Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences</funding><funding>Taishan Scholarship</funding><pagination>0823</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12352791</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8</volume><pubmed_abstract>Alcoholic cardiomyopathy (ACM) is a type of dilated cardiomyopathy unrelated to ischemia, which develops as a consequence of chronic alcohol consumption. While ethanol-induced irreversible cardiomyocyte death is implicated in ACM development and progression, the precise molecular mechanisms involved are still obscure. In the current study, we demonstrate that ethanol exposure promotes receptor-interacting serine/threonine-protein kinase 1 (RIPK1) autophosphorylation and enhances pRIPK1-associated apoptosis and necroptosis in ACM models both in vivo and in vitro. Through co-immunoprecipitation (Co-IP) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, we identified ubiquitin-specific protease 53 (USP53) as a pivotal deubiquitinase involved in modulating RIPK1 </pubmed_abstract><journal>Research (Washington, D.C.)</journal><pubmed_title>USP53 Drives Ethanol-Induced Myocardial Injury by Promoting K63 Deubiquitination-Dependent RIPK1 Activation at K377.</pubmed_title><pmcid>PMC12352791</pmcid><funding_grant_id>2022HWYQ-053</funding_grant_id><funding_grant_id>tsqn202306035</funding_grant_id><funding_grant_id>ZR2022QH262</funding_grant_id><funding_grant_id>2023-PT320-06</funding_grant_id><funding_grant_id>2023HWYQ-048</funding_grant_id><funding_grant_id>ZR2024MH154</funding_grant_id><funding_grant_id>ZR2022QH005</funding_grant_id><funding_grant_id>2023QNTD003</funding_grant_id><funding_grant_id>82271757</funding_grant_id><funding_grant_id>82400525</funding_grant_id><funding_grant_id>82200660</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Yuan C</pubmed_authors><pubmed_authors>Pan J</pubmed_authors><pubmed_authors>Dai S</pubmed_authors><pubmed_authors>Wang S</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Liu D</pubmed_authors><pubmed_authors>Zhao Y</pubmed_authors><pubmed_authors>Liu F</pubmed_authors><pubmed_authors>Wang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>USP53 Drives Ethanol-Induced Myocardial Injury by Promoting K63 Deubiquitination-Dependent RIPK1 Activation at K377.</name><description>Alcoholic cardiomyopathy (ACM) is a type of dilated cardiomyopathy unrelated to ischemia, which develops as a consequence of chronic alcohol consumption. While ethanol-induced irreversible cardiomyocyte death is implicated in ACM development and progression, the precise molecular mechanisms involved are still obscure. In the current study, we demonstrate that ethanol exposure promotes receptor-interacting serine/threonine-protein kinase 1 (RIPK1) autophosphorylation and enhances pRIPK1-associated apoptosis and necroptosis in ACM models both in vivo and in vitro. Through co-immunoprecipitation (Co-IP) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, we identified ubiquitin-specific protease 53 (USP53) as a pivotal deubiquitinase involved in modulating RIPK1 </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-29T16:32:24.408Z</modification><creation>2026-04-08T05:25:39.24Z</creation></dates><accession>S-EPMC12352791</accession><cross_references><pubmed>40822127</pubmed><doi>10.34133/research.0823</doi></cross_references></HashMap>